Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Molecules 2012, 17(6), 7415-7439; doi:10.3390/molecules17067415
Article

Application of 4D-QSAR Studies to a Series of Raloxifene Analogs and Design of Potential Selective Estrogen Receptor Modulators

1,2,* , 1,3, 4, 2,5, 1, 2, 5, 6 and 1,*
Received: 12 April 2012; in revised form: 4 June 2012 / Accepted: 5 June 2012 / Published: 15 June 2012
(This article belongs to the Special Issue QSAR and Its Applications)
Download PDF [753 KB, updated 18 June 2014; original version uploaded 18 June 2014]
Abstract: Four-dimensional quantitative structure-activity relationship (4D-QSAR) analysis was applied on a series of 54 2-arylbenzothiophene derivatives, synthesized by Grese and coworkers, based on raloxifene (an estrogen receptor-alpha antagonist), and evaluated as ERa ligands and as inhibitors of estrogen-stimulated proliferation of MCF-7 breast cancer cells. The conformations of each analogue, sampled from a molecular dynamics simulation, were placed in a grid cell lattice according to three trial alignments, considering two grid cell sizes (1.0 and 2.0 Å). The QSAR equations, generated by a combined scheme of genetic algorithms (GA) and partial least squares (PLS) regression, were evaluated by “leave-one-out” cross-validation, using a training set of 41 compounds. External validation was performed using a test set of 13 compounds. The obtained 4D-QSAR models are in agreement with the proposed mechanism of action for raloxifene. This study allowed a quantitative prediction of compounds’ potency and supported the design of new raloxifene analogs.
Keywords: four dimensional quantitative structure-activity relationship (4D-QSAR); ligand based drug design (LBDD); molecular modeling; estrogen receptor alpha (ERa); estrogen receptor beta (ERb); selective estrogen receptor modulator (SERM); raloxifene; ligand binding domain (LBD) four dimensional quantitative structure-activity relationship (4D-QSAR); ligand based drug design (LBDD); molecular modeling; estrogen receptor alpha (ERa); estrogen receptor beta (ERb); selective estrogen receptor modulator (SERM); raloxifene; ligand binding domain (LBD)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Sodero, A.C.R.; Romeiro, N.C.; da Cunha, E.F.F.; de Oliveira Magalhães, U.; de Alencastro, R.B.; Rodrigues, C.R.; Cabral, L.M.; Castro, H.C.; Albuquerque, M.G. Application of 4D-QSAR Studies to a Series of Raloxifene Analogs and Design of Potential Selective Estrogen Receptor Modulators. Molecules 2012, 17, 7415-7439.

AMA Style

Sodero ACR, Romeiro NC, da Cunha EFF, de Oliveira Magalhães U, de Alencastro RB, Rodrigues CR, Cabral LM, Castro HC, Albuquerque MG. Application of 4D-QSAR Studies to a Series of Raloxifene Analogs and Design of Potential Selective Estrogen Receptor Modulators. Molecules. 2012; 17(6):7415-7439.

Chicago/Turabian Style

Sodero, Ana Carolina Rennó; Romeiro, Nelilma Correia; da Cunha, Elaine Fontes Ferreira; de Oliveira Magalhães, Uiaran; de Alencastro, Ricardo Bicca; Rodrigues, Carlos Rangel; Cabral, Lúcio Mendes; Castro, Helena Carla; Albuquerque, Magaly Girão. 2012. "Application of 4D-QSAR Studies to a Series of Raloxifene Analogs and Design of Potential Selective Estrogen Receptor Modulators." Molecules 17, no. 6: 7415-7439.



Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert